INSIGHTS ON LIQUID DOSE MANUFACTURING

• Water For Injection: Strategic Utility And The Case For Outsourcing

  Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.

• Safe Syringe Solutions For Lipid Nanoparticles

  Prefilled syringes improve lipid nanoparticle dosing accuracy and administration. Advanced containment solutions with cross-linked coatings preserve stability and accelerate development timelines.

• The Fill/Finish Timeline: What Comes After Manufacturing

  The post-manufacturing backend of sterile injectable fill-finish operates in a strict sequence—encompassing inspection, testing, QA review, and complex labeling validation—requiring early planning to avoid timeline delays.

• Unlock A Faster, More Efficient Route To Commercialization

  Streamline commercialization with a variable-dose, disposable pen injector platform. Ideal for GLP-1 therapies, biosimilars, and generics, it combines intuitive patient handling with market entry.

• Drug Substance To Fill-Finish Handoff: What Sponsors Need To Know

  5/14/2026

  Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.

• Streamline Global Regulatory Submissions

  5/21/2026

  Discover a more streamlined approach with one accountable partner supporting regulatory submissions globally.

• Key Topics And Trends In Aseptic Filling

  1/9/2026

  Aseptic filling is vital yet often guided by outdated practices. Discover expert insights on modern technologies, evolving regulations, and data-driven strategies to improve compliance and reduce risk in this critical manufacturing step.

• Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance

  2/24/2026

  Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.

• How To Use Enzyme Indicators In An Aseptic Production Environment

  6/30/2026

  Discover how transitioning to quantitative validation data allows engineering teams to optimize decontamination timelines, slash system downtime, and minimize product carryover risks.